logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Oladapo Yeku

mass general brig ham cancer institute
H指数:21
被引数:3,891

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers

缺氧诱导的VEGF分泌促进对双特异性T细胞衔接器的抵抗

Signal Transduction and Targeted Therapy
IF52.7
2025-12-190
OAAI
Mengyao Xu; Syem K. Barakzai; Raj Kumar; Irva Veillard; Eugene Kim; Amy Bregar; Eric Eisenhauer; Richard Penson; Sara Bouberhan; Jennifer Filipi; Tina Colella; Tim Bond; Caroline Clark; Lawrence H. Lin; Jinpeng Ruan; Cheng Wang; Xingping Qin; Kristopher Sarosiek; Bo Rueda; Cesar Castro; David R. Spriggs; Oladapo O. Yeku
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45

鲁卡帕利用于新诊断晚期卵巢癌的维持治疗：来自III期ATHENA-MONO/GOG-3020/ENGOT-ov45研究5年随访的 interim 总体生存期、无进展生存期及安全性数据

Annals of Oncology
IF65.4
2025-10-180
OAAI
R.S. Kristeleit; S. Ghamande; A. Lisyanskaya; A. Oaknin; E. Prendergast; Y.B. Kim; J.Fuentes Pradera; R.D. Littell; B. Gao; G. Valabrega; D.M. O’Malley; A. Dean; C. Pisano; J. Buscema; D. Provencher; F. Zagouri; L.P. Martin; H.-H. Chou; F. Demirkiran; F. Ueland; A. Chudecka-Głaz; O. Yeku; M. Beiner; C. Anderson; V. Drochytek; R.N. Eskander; R. Agarwal; L. Maloney; D. Despain; C. Connor; M. Craib; D. Shih; K. Fujiwara; B.J. Monk
Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion

靶向紊乱的Hippo信号通路以预防肿瘤性肾上皮细胞的免疫逃逸

NATURE COMMUNICATIONS
IF15.7
2025-03-240
OA
Lv, Xiangmin; Liu, Jiyuan; Ruan, Jinpeng; Chen, Peichao; He, Chunbo; Zhao, Xingeng; Huang, Cong; Chen, Li; Wang, Hongbo; Hua, Guohua; Shi, Davie; Yang, Siyi; Moness, Madelyn L.; Montoute, Isabelle; Dhar, Anjali; Chen, Xingcheng; Kumar, Raj; Lu, Hu; Sadreyev, Ruslan; Yeku, Oladapo; Wu, Xu; Davis, John S.; Wang, Cheng
First results from phase II dose expansion cohort of transcon IL-2 β/γ in combination with standard of care chemotherapy for platinum resistant ovarian cancer (PROC) in the IL Believe trial

II期剂量扩展队列中，transcon IL-2 β/γ 与标准护理化疗联合治疗铂耐药卵巢癌（PROC）的初步结果（IL Believe 试验）。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Yeku, O.; Lee, J-Y.; Rimmel, B.; Kim, S-B.; Van Den Mooter, T.; Kichenadasse, G.; Krapp, C.; Slavsky, S.; Castro, D. Torrejon; Singel, S.; Kwatra, V.
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair (vol 15, 1568, 2024)
NATURE COMMUNICATIONS
IF15.7
2024-05-070
OAAI
Wang, Yumin; Gao, Boya; Zhang, Luyuan; Wang, Xudong; Zhu, Xiaolan; Yang, Haibo; Zhang, Fengqi; Zhu, Xueping; Zhou, Badi; Yao, Sean; Nagayama, Aiko; Lee, Sanghoon; Ouyang, Jian; Koh, Siang-Boon; Eisenhauer, Eric L.; Zarrella, Dominique; Lu, Kate; Rueda, Bo R.; Zou, Lee; Su, Xiaofeng A.; Yeku, Oladapo; Ellisen, Leif W.; Wang, Xiao-Song; Lan, Li
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Bcl-xl和MEK联合Navitoclax和曲美替尼在KRAS或NRAS突变型晚期实体瘤中的I/II期研究

CLINICAL CANCER RESEARCH
IF10.2
2024-03-085
OAAI
Corcoran, Ryan B.; Do, Khanh T.; Kim, Jeong E.; Cleary, James M.; Parikh, Aparna R.; Yeku, Oladapo O.; Xiong, Niya; Weekes, Colin D.; Veneris, Jennifer; Ahronian, Leanne G.; Mauri, Gianluca; Tian, Jun; Norden, Bryanna L.; Michel, Alexa G.; Van Seventer, Emily E.; Siravegna, Giulia; Camphausen, Kyle; Chi, Gary; Fetter, Isobel J.; Brugge, Joan S.; Chen, Helen; Takebe, Naoko; Penson, Richard T.; Juric, Dejan; Flaherty, Keith T.; Sullivan, Ryan J.; Clark, Jeffrey W.; Heist, Rebecca S.; Matulonis, Ursula A.; Liu, Joyce F.; Shapiro, Geoffrey I.
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma
BRITISH JOURNAL OF CANCER
IF6.8
2024-03-042
OA
Matoba, Yusuke; Zarrella, Dominique T.; Pooladanda, Venkatesh; Mohammadabadi, Maryam Azimi; Kim, Eugene; Kumar, Shaan; Xu, Mengyao; Qin, Xingping; Ray, Lauren J.; Devins, Kyle M.; Kumar, Raj; Kononenko, Artem; Eisenhauer, Eric; Veillard, Irva E.; Yamagami, Wataru; Hill, Sarah J.; Sarosiek, Kristopher A.; Yeku, Oladapo O.; Spriggs, David R.; Rueda, Bo R.
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair

减数分裂蛋白SYCP2通过R环介导的DNA修复赋予对DNA损伤剂的抗性

NATURE COMMUNICATIONS
IF15.7
2024-02-213
OAAI
Wang, Yumin; Gao, Boya; Zhang, Luyuan; Wang, Xudong; Zhu, Xiaolan; Yang, Haibo; Zhang, Fengqi; Zhu, Xueping; Zhou, Badi; Yao, Sean; Nagayama, Aiko; Lee, Sanghoon; Ouyang, Jian; Koh, Siang-Boon; Eisenhauer, Eric L.; Zarrella, Dominique; Lu, Kate; Rueda, Bo R.; Zou, Lee; Su, Xiaofeng A.; Yeku, Oladapo; Ellisen, Leif W.; Wang, Xiao-Song; Lan, Li
Ubamatamab (MUC16xCD3 bispecific antibody) with cemiplimab (anti-PD-1 antibody) in recurrent ovarian cancer: Phase I dose-escalation study

Ubamatamab (MUC16xCD3双特异性抗体) 联合cemiplimab (anti-PD-1抗体) 治疗复发性卵巢癌: I期剂量递增研究

ANNALS OF ONCOLOGY
IF65.4
2023-10-013
OA
O'Cearbhaill, R. E.; Moore, K. N.; Yeku, O.; Liu, J. F.; Bouberhan, S.; Hamilton, E. P.; Hou, J. Y.; Van Nieuwenhuysen, E.; Papadimitriou, K.; Yoo, S-Y.; Govindraj, S.; Brouwer-Visser, J.; Peterman, M.; Schmidt, T.; Barnes, B.; Madia, P.; Zhu, M.; Uldrick, T. S.; Miller, E. A.; O'Malley, D.

研究方向

暂未获取到该数据
D
David R. Spriggs
H 指数:71论文数:425被引数:1.7万
B
Bo R. Rueda
H 指数:57论文数:468被引数:9,370
R
Raj Kumar
H 指数:22论文数:99被引数:3,175
R
Renier J. Brentjens
H 指数:77论文数:395被引数:3.5万
T
Terence J. Purdon
H 指数:28论文数:74被引数:5,843
I
Irva Veillard
H 指数:1论文数:14被引数:11
M
Mengyao Xu
H 指数:8论文数:46被引数:326
E
Eugene Kim
H 指数:13论文数:39被引数:1,470
E
Eric Eisenhauer
H 指数:33论文数:219被引数:5,483
D
Dominique T. Zarrella
H 指数:5论文数:38被引数:280